Credit: Michelle Lehman/Oak Ridge National Laboratory, U.S. Dept. of Energy
Researchers used the Summit supercomputer to identify existing drug compounds likely to bind to the main "spike" protein of the SARS-CoV-2 coronavirus, blocking it from infecting human cells.